Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Medgenics’ Receives Allowance for Key European Patent

January 23, 2012 By AxoGen, Inc.

MISGAV, Israel & SAN FRANCISCO–(BUSINESS WIRE)–Medgenics, Inc., the developer of a novel technology for the
sustained production and delivery of therapeutic proteins in patients using
their own tissue, today announced that the Company received notice of
‘Intention to Grant from the European Patent Office for the patent application
entitled “USE OF DERMAL MICRO ORGANS,” with allowed claims covering a core
element of its Biopump™ protein therapy technology.

A counterpart patent in the United States was issued in
December 2008, with rights extending to November 2023. The patent estate
covering the Biopump includes compositions, methods of use and methods of
manufacture, and includes issued patents in the United
States, as well as pending applications in the United States
and various foreign jurisdictions.

Commenting on the European patent allowance, Andrew L.
Pearlman, Ph.D., President and Chief Executive Officer of Medgenics, said: “We
will be delighted to add this European patent to our growing intellectual
property portfolio. This patent is important as it protects key elements of our
protein production technology. These claims provide significant protection for
our proprietary technology and create significant barriers of entry to any
would-be competitors.”

“Medgenics has pioneered the development of sustained
production and delivery of therapeutic proteins using the patient’s own intact
tissue, which is a key differentiating factor of our technology. This patent,
like its counterpart U.S.
patent, is critical to protecting this unique tissue technology and its
resulting protein production capabilities,” added Dr. Pearlman.

About Medgenics

Medgenics is developing and commercializing Biopump™, a proprietary
tissue-based platform technology for the sustained production and delivery of
therapeutic proteins using the patient’s own skin biopsy for the treatment of a
range of chronic diseases including anemia, hepatitis C and hemophilia.
Medgenics believes this approach has multiple benefits compared with current
treatments, which include regular and costly injections of therapeutic
proteins.

Medgenics has three long-acting protein therapy products in
development based on this technology:

  • EPODURE (now completing a Phase I/II dose-ranging trial) to
    produce and deliver erythropoietin for many months from a single
    administration, has demonstrated elevation and stabilization of hemoglobin
    levels in anemic patients for six to more than 36 months;
  • INFRADURE (planning to commence a Phase I/II trial in Israel in 1H12
    in hepatitis C) to produce a sustained therapeutic dose of interferon-alpha for
    use in the treatment of hepatitis;
  • HEMODURE is a sustained Factor VIII therapy for the
    prophylactic treatment of hemophilia, now in development.

Medgenics intends to develop its innovative products and
bring them to market via strategic partnerships with major pharmaceutical
and/or medical device companies.

In addition to treatments for anemia, hepatitis and
hemophilia, Medgenics plans to develop and/or out-license a pipeline of future
Biopump™ products targeting the large and rapidly growing global protein
therapy market, which is forecast to reach $132 billion in 2013. Other
potential applications for Biopumps™ include multiple sclerosis, arthritis,
pediatric growth hormone deficiency, obesity and diabetes.

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 13, 2022
Our Pre-Post-DeviceTalks Boston episode, also MedtronicTalks replay with Gastro CMO Austin Chiang
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech